Loading...
Regulatory T cells move in when gliomas say “I-DO”
Indoleamine 2,3-dioxygenase (IDO) is an enzyme with known immunosuppressive and tolerogenic effects in cancer. Mounting evidence has associated IDO expression with the induction of regulatory T cells and malignant progression. IDO inhibition may therefore provide a promising therapeutic approach for...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662964/ https://ncbi.nlm.nih.gov/pubmed/23052252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2801 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|